Related Experiment Video

Updated: Jun 17, 2026

A Multicenter MRI Protocol for the Evaluation and Quantification of Deep Vein Thrombosis
10:26

A Multicenter MRI Protocol for the Evaluation and Quantification of Deep Vein Thrombosis

Published on: June 2, 2015

The ATTRACT trial: rationale for early intervention for iliofemoral DVT

Anthony J Comerota1

  • 1Jobst Vascular Center, The Toledo Hospital, Toledo, OH 43606, USA. marilyn.gravett@promedica.org

Perspectives in Vascular Surgery and Endovascular Therapy
|January 6, 2010
PubMed

Insights

Catheter-directed thrombolysis may improve outcomes for iliofemoral deep vein thrombosis (DVT) compared to anticoagulation alone. The ATTRACT trial investigates its effectiveness in reducing postthrombotic syndrome over 24 months.

Area of Science:

  • Vascular Medicine
  • Interventional Cardiology
  • Clinical Trials

Background:

  • Anticoagulation is the standard for acute deep vein thrombosis (DVT).
  • Early thrombus removal in iliofemoral DVT may improve outcomes.
  • Limited evidence exists comparing anticoagulation alone versus early thrombus removal.

Purpose of the Study:

  • To evaluate the efficacy of catheter-directed thrombolysis plus anticoagulation versus anticoagulation alone for iliofemoral DVT.
  • To determine the impact on postthrombotic syndrome incidence and severity.
  • To assess effects on venous valve function and quality of life.

Main Methods:

  • The ATTRACT trial is a randomized controlled trial.
  • Patients with iliofemoral or femoropopliteal DVT were stratified.
  • Intervention groups: standard anticoagulation vs. anticoagulation plus catheter-directed thrombolysis.

Main Results:

  • Primary outcome: incidence of postthrombotic syndrome at 24 months.
  • Secondary outcomes: venous valve function, quality of life, recurrent DVT, bleeding events.
  • Data analysis will compare outcomes between the two treatment arms.

Conclusions:

  • Findings will inform clinical practice guidelines for DVT management.
  • The study aims to establish optimal treatment strategies for iliofemoral DVT.
  • Results will guide decisions on early thrombus removal versus anticoagulation alone.

More Related Videos

Upper-extremity Approach for Secondary Access in Transfemoral Transcatheter Aortic Valve Implantation06:04

Upper-extremity Approach for Secondary Access in Transfemoral Transcatheter Aortic Valve Implantation

Published on: August 8, 2025

Related Concept Videos

Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies01:20

Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies

The key difference between Superficial Vein Thrombosis (SVT) and Deep Vein Thrombosis (DVT) lies in their location and severity.Clinical ManifestationsSVT typically presents with localized pain, tenderness, and redness along the course of a superficial vein, often accompanied by a palpable, cord-like structure under the skin. This condition is usually less dangerous than DVT but can be uncomfortable and may lead to complications such as cellulitis or, rarely, a clot extension into the deep...
Venous Thrombosis I: Introduction01:30

Venous Thrombosis I: Introduction

Venous thrombosis, the most common disorder of the veins, involves the formation of a thrombus or blood clot associated with vein inflammation. It can be classified as either superficial vein thrombosis or deep vein thrombosis.Superficial Vein Thrombosis: This involves the formation of a thrombus in a superficial vein, usually the greater or lesser saphenous vein. Though less severe than deep vein thrombosis (DVT), SVT can lead to complications if untreated.Deep Vein Thrombosis (DVT): This...
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants01:18

Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants

Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Varicose Veins II: Diagnostic Studies and Interprofessional Care01:26

Varicose Veins II: Diagnostic Studies and Interprofessional Care

Varicose veins, or varicosities, develop when the valves in the veins, which control blood flow, weaken or damage. It causes blood to pool and the veins to enlarge. Understanding the clinical manifestations, diagnostic approaches, and management options for varicose veins is crucial for effective treatment and relief.Clinical manifestationsClinical manifestations of varicose veins include a heavy, achy feeling or pain after prolonged standing or sitting. This discomfort can often be relieved by...
Venous Thrombosis IV: Nursing Management01:30

Venous Thrombosis IV: Nursing Management

Nursing management begins with a thorough assessment of the patient's health history. Key factors include trauma to veins, peripherally inserted central catheters, varicose veins, recent pregnancy or childbirth, surgery, bacteremia, prolonged bed rest, atrial fibrillation, COPD, heart failure, cancer, coagulation disorders, myocardial infarction, spinal cord injury, stroke, prolonged travel, recent bone fractures, and dehydration. Review medication intake, particularly oral contraceptives,...